Larotaxel is a taxane-based antineoplastic agent that functions as a microtubule destabilizer by inhibiting tubulin polymerization, effectively arresting cell division in cancer treatment. This drug is… Read more
Larotaxel is a taxane-based antineoplastic agent that functions as a microtubule destabilizer by inhibiting tubulin polymerization, effectively arresting cell division in cancer treatment. This drug is primarily indicated for patients with metastatic or unresectable soft tissue sarcoma who have previously undergone chemotherapy. To support the rigorous demands of pharmaceutical analysis, this category includes the active pharmaceutical ingredient alongside stable isotope labelled compounds such as Larotaxel-d3, Larotaxel-d9, and the isotopically enriched d3,13C2 variant. These high-quality reference standards are essential tools in modern laboratories for quantitative bioanalysis, impurity profiling, and method validation. By utilizing these labelled internal standards, researchers can ensure accurate quantification and consistency during quality control procedures, facilitating the development and monitoring of this potent chemotherapeutic agent throughout its lifecycle.